查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1485771

即時基因檢測市場，依樣本、依產品、依平台、依最終用戶、依國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Point of Care Genetic Testing Market, By Sample, By Product, By Platform, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年，即時基因檢測市場規模為 65.8354 億美元，2024 年至 2032 年複合年成長率為 12.35%。

即時基因檢測市場-市場動態

全球傳染病發生率上升

全球性傳染病的日益普及正在推動對即時基因檢測 (POCGT) 的需求不斷增加。根據國家醫學圖書館的數據，傳染病仍然是導致全球發病和死亡的主要因素之一，每年在全球範圍內導致超過 5,200 萬人 (33%) 死亡。由於傳染病在全球範圍內構成了重大的公共衛生課題，因此迫切需要可直接在照護端部署的快速、準確的診斷解決方案。傳統的實驗室為基礎的檢測方法通常會延遲診斷和治療開始，這可能會加劇傳染病的傳播。 POCGT 透過提供及時結果來應對這項課題，使醫療保健提供者能夠及時識別傳染源並啟動適當的治療策略。

即時基因檢測市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 12.35% 左右的複合年成長率成長

根據樣本區隔，預計血液將在 2023 年顯示最大的市場佔有率

從平台區隔來看，橫向層析偵測是2023年的主導類型

根據最終用戶區隔，臨床實驗室是 2023 年的主導類型

依地區分類，北美是 2023 年的主要收入來源

即時基因檢測市場-區隔分析：

全球即時基因檢測市場根據樣本、產品、平台、最終用戶和地區進行區隔。

根據樣本，市場分為兩類：血液包括使用血液樣本進行的基因檢測和診斷程序，提供對各種健康狀況的深入了解，例如傳染病、遺傳性疾病和血液相關異常。使用尿液樣本進行基因檢測和診斷分析是另一個關鍵部分，通常用於檢測泌尿道感染、腎臟疾病和代謝紊亂。

根據應用，市場分為兩類： 血糖監測產品包括用於監測血糖水平的設備和系統，這對於管理糖尿病和相關代謝狀況至關重要。心臟代謝監測產品專注於監測心血管和代謝健康參數，幫助預防、診斷和管理高血壓、血脂異常和心臟病等疾病。

即時基因檢測市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。

由於先進的醫療基礎設施和有利的報銷政策，北美和歐洲在採用方面處於領先地位。隨著醫療保健投資的增加和個人化醫療意識的提高，亞太地區顯示出巨大的成長潛力。在改善醫療保健服務和解決傳染病負擔的努力的推動下，拉丁美洲和非洲的新興市場也正在見證這種技術的採用。總體而言，全球擴張和創新推動了床邊基因檢測不斷發展的模式。

即時基因檢測市場-競爭格局：

該市場的特點是雅培實驗室 (Abbott Laboratories)、賽默飛世爾科技 (Thermo Fisher Scientific) 和 Qiagen 等主要參與者之間的激烈競爭。這些公司以創新產品和策略性收購佔據主導地位。 23andMe 和 Myriad Genetics 等新創公司在推動創新和市場顛覆方面也發揮著重要作用。重點仍然是開發方便用戶使用且準確的測試解決方案，以滿足不斷變化的醫療保健需求。

最近的發展：

2023 年 1 月，Cipla Ltd. 推出了 Cippoint，這是一種即時檢測設備，可識別多種健康狀況，包括心臟標記、糖尿病、傳染病、生育力和甲狀腺功能。

目錄

第 1 章：即時基因檢測市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 即時基因檢測市場片段（依樣本）
    • 即時基因檢測市場片段（依產品）
    • 依平台分類的即時基因檢測市場片段
    • 最終用戶的即時基因測試市場片段
    • 依國家/地區分類的即時基因檢測市場片段
    • 依地區分類的即時基因檢測市場片段
  • 競爭洞察

第 3 章：即時基因檢測主要市場趨勢

  • 即時基因檢測市場促進因素
    • 市場促進因素的影響分析
  • 即時基因檢測市場限制
    • 市場限制影響分析
  • 即時基因檢測市場機會
  • 即時基因檢測市場未來趨勢

第 4 章：即時基因檢測產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：即時基因檢測市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：即時基因檢測市場格局

  • 2023 年即時基因檢測市佔分析
  • 依主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：即時基因檢測市場 - 依樣本

  • 概述
    • 區隔市場佔有率分析（依樣本）
    • 血
    • 尿

第 8 章：即時基因檢測市場 - 依產品

  • 概述
    • 依產品分類的區隔市場佔有率分析
    • COVID-19 測試產品
    • 血糖監測產品
    • 心臟代謝監測產品
    • 傳染病檢測產品
    • 凝血監測產品
    • 其他 POC 產品

第 9 章：即時基因檢測市場 - 依平台

  • 概述
    • 依平台分類的區隔市場佔有率分析
    • 側流分析
    • 量油尺
    • 微流控
    • 分子診斷
    • 免疫測定
    • 其他分子診斷技術

第 10 章：床邊基因檢測市場 - 依最終用戶

  • 概述
    • 依產品分類的區隔市場佔有率分析
    • 臨床實驗室
    • 醫院、重症監護中心、緊急護理中心
    • 家庭護理和自我測試

第 11 章：即時基因檢測市場 - 依地理位置

  • 介紹
    • 依地理位置分類的區隔市場佔有率分析
  • 北美洲
    • 概述
    • 北美床邊基因檢測主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（依樣本）
    • 北美市場規模和預測（依產品）
    • 北美市場規模和預測（依平台）
    • 北美市場規模和預測（依最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲床邊基因檢測主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模與預測（依樣本）
    • 歐洲市場規模和預測（依產品）
    • 歐洲市場規模和預測（依平台）
    • 歐洲市場規模和預測（依最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區床邊基因檢測主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模與預測（依樣本）
    • 亞太地區市場規模與預測（依產品）
    • 亞太地區市場規模和預測（依平台）
    • 亞太地區市場規模和預測（依最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲的即時基因檢測主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模與預測（依樣本）
    • 拉丁美洲市場規模與預測（依產品）
    • 拉丁美洲市場規模與預測（依平台）
    • 拉丁美洲市場規模和預測（依最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲床邊基因檢測主要製造商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依樣本）
    • 中東和非洲市場規模及預測（依產品）
    • 中東和非洲市場規模及預測（依平台）
    • 中東和非洲市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：關鍵供應商分析 - 即時基因檢測產業

  • 競爭儀表板
  • 公司簡介
    • A. Menarini Diagnostics SRL
    • Abaxis
    • Abbott
    • Acon Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Ascensia Diabetes Care Holdings Ag
    • Bayer AG
    • bioMerieux
    • Bio-Rad Laboratories, Inc.
    • Danaher
    • Diasorin SPA
    • F. Hoffmann-La Roche AG
    • Fluxergy
    • Grifols, SA
    • Lifescan Ip Holdings, Llc
    • Mankind Pharma
    • Nipro Diagnostics
    • Nova Biomedical
    • OraSure Technologies, Inc.
    • Precision Biosensor, Inc.
    • QIAGEN
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2669

REPORT HIGHLIGHT

Point of Care Genetic Testing Market size was valued at USD 6,583.54 million in 2023, expanding at a CAGR of 12.35% from 2024 to 2032.

Point-of-care genetic testing involves genetic testing procedures conducted directly at the patient's location, providing immediate results for clinical decision-making. The increasing adoption of portable and handheld genetic testing devices facilitates decentralized testing and empowers patients with greater control over their healthcare. However, the market faces restraints such as regulatory challenges surrounding the interpretation and communication of genetic test results, and concerns about data privacy and security. Opportunities in this market stem from the potential for personalized medicine, where genetic testing at the point of care can guide treatment decisions tailored to individual patients' genetic profiles, leading to more effective healthcare delivery.

Point of Care Genetic Testing Market- Market Dynamics

Rising incidence of infectious diseases worldwide

The increasing prevalence of infectious diseases worldwide is driving a heightened need for Point of Care Genetic Testing (POCGT). According to the National Library of Medicine, infectious diseases continue to stand as one of the primary factors contributing to morbidity and mortality worldwide, responsible for over 52 million (33%) deaths annually on a global scale. With infectious diseases posing significant public health challenges globally, there is a pressing need for rapid and accurate diagnostic solutions that can be deployed directly at the point of care. Traditional laboratory-based testing methods often involve delays in diagnosis and treatment initiation, which can exacerbate the spread of infectious diseases. POCGT addresses this challenge by providing timely results, enabling healthcare providers to promptly identify infectious agents and initiate appropriate treatment strategies.

Point of Care Genetic Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.35% over the forecast period (2024-2032)

Based on sample segmentation, Blood was predicted to show maximum market share in the year 2023

Based on Platform segmentation, Lateral Flow Assays was the leading type in 2023

Based on End-user segmentation, Clinical Laboratories was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Point of Care Genetic Testing Market- Segmentation Analysis:

The Global Point of Care Genetic Testing Market is segmented on the basis of Sample, Product, Platform, End User, and Region.

The market is divided into two categories based on sample: Blood encompasses genetic testing and diagnostic procedures conducted using blood samples, offering insights into various health conditions such as infectious diseases, genetic disorders, and blood-related abnormalities. Genetic testing and diagnostic analysis using urine samples form another crucial segment, often utilized in detecting urinary tract infections, kidney diseases, and metabolic disorders.

The market is divided into two categories based on application: Glucose monitoring products encompass devices and systems for monitoring blood glucose levels, essential for managing diabetes and related metabolic conditions. Cardiometabolic monitoring products focus on monitoring cardiovascular and metabolic health parameters, aiding in the prevention, diagnosis, and management of conditions such as hypertension, dyslipidemia, and heart disease.

Point of Care Genetic Testing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America and Europe lead in adoption due to advanced healthcare infrastructure and favorable reimbursement policies. The Asia-Pacific region shows significant growth potential with increasing healthcare investments and rising awareness of personalized medicine. Emerging markets in Latin America and Africa are also witnessing adoption, driven by efforts to improve healthcare access and address infectious disease burdens. Overall, global expansion and innovation drive the evolving landscape of point-of-care genetic testing.

Point of Care Genetic Testing Market- Competitive Landscape:

The market is characterized by intense competition among key players such as Abbott Laboratories, Thermo Fisher Scientific, and Qiagen. These companies dominate with innovative products and strategic acquisitions. Startups including 23andMe and Myriad Genetics also play significant roles, in driving innovation and market disruption. The focus remains on developing user-friendly and accurate testing solutions to meet evolving healthcare needs.

Recent Developments:

In January 2023, Cipla Ltd. launched Cippoint, a point-of-care testing device that identifies a wide range of health conditions, including cardiac markers, diabetes, infectious diseases, fertility, and thyroid function.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL POINT OF CARE GENETIC TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

A. Menarini Diagnostics S.R.L.

Abaxis

Abbott

Acon Laboratories, Inc.

Agilent Technologies, Inc.

Ascensia Diabetes Care Holdings Ag

Bayer AG

bioMerieux

Bio-Rad Laboratories, Inc.

Danaher

Diasorin S.P.A.

F. Hoffmann-La Roche AG

Fluxergy

Grifols, S.A.

Lifescan Ip Holdings, Llc

Mankind Pharma

Nipro Diagnostics

Nova Biomedical

OraSure Technologies, Inc.

Precision Biosensor, Inc.

QIAGEN

Others

GLOBAL POINT OF CARE GENETIC TESTING MARKET, BY SAMPLE- MARKET ANALYSIS, 2019 - 2032

  • Blood
  • Urine

GLOBAL POINT OF CARE GENETIC TESTING MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • COVID-19 Test Products
  • Glucose Monitoring Products
  • Cardiometabolic Monitoring Products
  • Infectious Disease Testing Products
  • Coagulation Monitoring Products
  • Other POC Products

GLOBAL POINT OF CARE GENETIC TESTING MARKET, BY PLATFORM- MARKET ANALYSIS, 2019 - 2032

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays
  • Other Molecular Diagnostic Technologies

GLOBAL POINT OF CARE GENETIC TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Clinical Laboratories
  • Hospitals, Critical Care Centers, Urgent care centers
  • Home Care & Self Testing

GLOBAL POINT OF CARE GENETIC TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Point of Care Genetic Testing Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Point of Care Genetic Testing Market Snippet By Sample
    • 2.1.2.Point of Care Genetic Testing Market Snippet By Product
    • 2.1.3.Point of Care Genetic Testing Market Snippet By Platform
    • 2.1.4.Point of Care Genetic Testing Market Snippet By End User
    • 2.1.5.Point of Care Genetic Testing Market Snippet by Country
    • 2.1.6.Point of Care Genetic Testing Market Snippet by Region
  • 2.2.Competitive Insights

3.Point of Care Genetic Testing Key Market Trends

  • 3.1.Point of Care Genetic Testing Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Point of Care Genetic Testing Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Point of Care Genetic Testing Market Opportunities
  • 3.4.Point of Care Genetic Testing Market Future Trends

4.Point of Care Genetic Testing Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Point of Care Genetic Testing Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Point of Care Genetic Testing Market Landscape

  • 6.1.Point of Care Genetic Testing Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Point of Care Genetic Testing Market - By Sample

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Sample, 2023 & 2032 (%)
    • 7.1.2.Blood
    • 7.1.3.Urine

8.Point of Care Genetic Testing Market - By Product

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 8.1.2.COVID-19 Test Products
    • 8.1.3.Glucose Monitoring Products
    • 8.1.4.Cardiometabolic Monitoring Products
    • 8.1.5.Infectious Disease Testing Products
    • 8.1.6.Coagulation Monitoring Products
    • 8.1.7.Other POC Products

9.Point of Care Genetic Testing Market - By Platform

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Platform, 2023 & 2032 (%)
    • 9.1.2.Lateral Flow Assays
    • 9.1.3.Dipsticks
    • 9.1.4.Microfluidics
    • 9.1.5.Molecular Diagnostics
    • 9.1.6.Immunoassays
    • 9.1.7.Other Molecular Diagnostic Technologies

10.Point of Care Genetic Testing Market - By End User

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 10.1.2.Clinical Laboratories
    • 10.1.3.Hospitals, Critical Care Centers, Urgent care centers
    • 10.1.4.Home Care & Self Testing

11.Point of Care Genetic Testing Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Point of Care Genetic Testing Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Point of Care Genetic Testing Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Point of Care Genetic Testing Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Point of Care Genetic Testing Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Point of Care Genetic Testing Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Point of Care Genetic Testing Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.A. Menarini Diagnostics S.R.L.
    • 12.2.2.Abaxis
    • 12.2.3.Abbott
    • 12.2.4.Acon Laboratories, Inc.
    • 12.2.5.Agilent Technologies, Inc.
    • 12.2.6.Ascensia Diabetes Care Holdings Ag
    • 12.2.7.Bayer AG
    • 12.2.8.bioMerieux
    • 12.2.9.Bio-Rad Laboratories, Inc.
    • 12.2.10.Danaher
    • 12.2.11.Diasorin S.P.A.
    • 12.2.12.F. Hoffmann-La Roche AG
    • 12.2.13.Fluxergy
    • 12.2.14.Grifols, S.A.
    • 12.2.15.Lifescan Ip Holdings, Llc
    • 12.2.16.Mankind Pharma
    • 12.2.17.Nipro Diagnostics
    • 12.2.18.Nova Biomedical
    • 12.2.19.OraSure Technologies, Inc.
    • 12.2.20.Precision Biosensor, Inc.
    • 12.2.21.QIAGEN
    • 12.2.22.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Point of Care Genetic Testing Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, By Sample
  • TABLE Global Point of Care Genetic Testing Market, By Sample 2019-2032 (USD Million)
  • TABLE Point of Care Genetic Testing Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, By Product
  • TABLE Global Point of Care Genetic Testing Market, By Product 2019-2032 (USD Million)
  • TABLE Point of Care Genetic Testing Market: Distribution Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, By Platform
  • TABLE Global Point of Care Genetic Testing Market, By Platform 2019-2032 (USD Million)
  • TABLE Point of Care Genetic Testing Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, By End User
  • TABLE Global Point of Care Genetic Testing Market, By End User 2019-2032 (USD Million)
  • TABLE Point of Care Genetic Testing Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Point of Care Genetic Testing Market, by Region 2019-2032 (USD Million)
  • TABLE North America Point of Care Genetic Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Point of Care Genetic Testing Market, By Sample, 2019-2032 (USD Million)
  • TABLE North America Point of Care Genetic Testing Market, By Product, 2019-2032 (USD Million)
  • TABLE North America Point of Care Genetic Testing Market, By Platform, 2019-2032 (USD Million)
  • TABLE North America Point of Care Genetic Testing Market, By End User, 2019-2032 (USD Million)
  • TABLE Europe Point of Care Genetic Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Point of Care Genetic Testing Market, By Sample, 2019-2032 (USD Million)
  • TABLE Europe Point of Care Genetic Testing Market, By Product, 2019-2032 (USD Million)
  • TABLE Europe Point of Care Genetic Testing Market, By Platform, 2019-2032 (USD Million)
  • TABLE Europe Point of Care Genetic Testing Market, By End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Point of Care Genetic Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Point of Care Genetic Testing Market, By Sample, 2019-2032 (USD Million)
  • TABLE Asia Pacific Point of Care Genetic Testing Market, By Product, 2019-2032 (USD Million)
  • TABLE Asia Pacific Point of Care Genetic Testing Market, By Platform, 2019-2032 (USD Million)
  • TABLE Asia Pacific Point of Care Genetic Testing Market, By End User, 2019-2032 (USD Million)
  • TABLE Latin America Point of Care Genetic Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Point of Care Genetic Testing Market, By Sample, 2019-2032 (USD Million)
  • TABLE Latin America Point of Care Genetic Testing Market, By Product, 2019-2032 (USD Million)
  • TABLE Latin America Point of Care Genetic Testing Market, By Platform, 2019-2032 (USD Million)
  • TABLE Latin America Point of Care Genetic Testing Market, By End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Point of Care Genetic Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Point of Care Genetic Testing Market, By Sample, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Point of Care Genetic Testing Market, By Product, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Point of Care Genetic Testing Market, By Platform, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Point of Care Genetic Testing Market, By End User, 2019-2032 (USD Million)